IBI and SecureTeq Partner on Biodefense Security Management

ROCKVILLE, MD /BUSINESS WIRE/ -- Innovative Biosensors Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, and SecureTeq Corp., a company providing proprietary software coupled with unique services and solutions for business continuity, commercial, and government building security, announced that they have formed a partnership to integrate and commercialize facility- and infrastructure-security management systems globally.

IBI's proprietary BioFlash Biological Aerosol Collection, Detection, and Identification System provides near real-time, specific, and sensitive detection of up to 21 biological threat agents in single or multi-test formats. SecureTeq's core products offer total, integrated detection solutions for chemical, biological, radiological, nuclear, and explosive events, together with video (CBRNE+V), employing unique proprietary software and best-in-class detectors and sensors for the protection of high-risk buildings, critical infrastructure, transportation hubs, government, and defense facilities.

"SecureTeq's open-architecture solution brings together best-in-class threat-detection technologies into a single, seamless monitoring and management platform, and we are excited to have the opportunity to expand the usability of BioFlash by adding this valuable biological-detection capability," said Richard Thomas, IBI's Vice President of Business Development.

"BioFlash is the only system that has integrated the combination of collection, detection, and identification facets and which can be further integrated with the SecureTeq architecture to vastly expand it's capabilities and the confidence it delivers," said Anthony D. Bashall, SecureTeq's Executive Vice President, Technology and Corporate Development.

About Innovative Biosensors
Innovative Biosensors Inc. (IBI) is a privately held company, developing novel technologies for the rapid detection of pathogens in biodefense applications and human clinical diagnostics. IBI has tailored its technology to rapidly and sensitively detect biological threats in building security, military, and civil defense applications. Additionally, the technology platform is being used to develop rapid tests for the detection of hospital-acquired infections.

About SecureTeq
SecureTeq Corp. is privately held and was founded in 2001 by a team of security engineers, computer scientists, and former FBI special agents to provide leading-edge threat-detection solutions for private industry, law enforcement, and government departments. SecureTeq uses proprietary software coupled with best-in-class sensors and detectors overlaid with human expertise to Create Intelligence from Data. SecureTeq provides total solutions to a variety of commercial clients, especially those in the financial community, as well as local, state, and federal entities, using best-in-class CBRNE sensors and detectors from a variety of manufacturers. SecureTeq fully integrates them within its proprietary open-architecture SecureTeq FUSION software platform that seamlessly integrates with building control and security systems.